Your session is about to expire
← Back to Search
Other
Sunflower Lecithin for Meibomian Gland Dysfunction
N/A
Waitlist Available
Research Sponsored by George Washington University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
Summary
This trial is testing if sunflower lecithin capsules can help adults with dry eye disease by improving their meibomian gland function. Participants will take these capsules daily for a few months, and their eye dryness will be measured before and after the treatment.
Eligible Conditions
- Meibomian Gland Dysfunction
- Dry Eye Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from Baseline of the SPEED questionnaire score at Day 90
Secondary study objectives
Change from Baseline of Fluorescein Tear Break-Up Time (Seconds) at Day 90
Change in number of MMP-positive eyes at Day 90
Least Squares Mean Change from Baseline in Meibomian Gland Score (MGS) at Day 90
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Sunflower LecithinExperimental Treatment1 Intervention
Total 4800 mg sunflower lecithin per day taken in 4 softgel capsules
Group II: Olive OilPlacebo Group1 Intervention
Total 4000 mg olive oil per day taken in 4 softgel capsules
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sunflower lecithin
2023
N/A
~40
Find a Location
Who is running the clinical trial?
Virginia Lions Institute FoundationUNKNOWN
George Washington UniversityLead Sponsor
250 Previous Clinical Trials
458,779 Total Patients Enrolled
1 Trials studying Meibomian Gland Dysfunction
50 Patients Enrolled for Meibomian Gland Dysfunction
David Belyea, MDStudy ChairThe George Washington University
1 Previous Clinical Trials
81 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger